Developments in intracerebral stem cell grafts

Expert Review of Neurotherapeutics

Volumn 15, Issue 4, 2015, Pages 381-393

  Reyes, Stephanny ^a   Tajiri, Naoki ^a   Borlongan, Cesar V ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

cell delivery; neurodegeneration; neurological disorders; stem cell therapy; translational research

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; CEREBROVASCULAR ACCIDENT; HUMAN; HUNTINGTON CHOREA; INTRACEREBRAL STEM CELL GRAFT; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NONHUMAN; PARKINSON DISEASE; REVIEW; SHY DRAGER SYNDROME; STEM CELL TRANSPLANTATION; TRAUMATIC BRAIN INJURY; ANIMAL; BIOLOGICAL THERAPY; BRAIN INJURIES; CELL ENGINEERING; DISEASE MODEL; PHYSIOLOGY; PROCEDURES; STEM CELL;

ANIMALS; BRAIN INJURIES; CELL ENGINEERING; CELL- AND TISSUE-BASED THERAPY; DISEASE MODELS, ANIMAL; HUMANS; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84925873011     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.2015.1021787     Document Type: Review

References (107)

1. Brain disorders: by the numbers.McGovern Institute For Brain Research at MIT.Cambridge, MA: mcGovern institute for brain research.2014.Available from: http://.mcgovern.mit.edu/brain-disorders/by-Thenumbers
2. The challenge of neurodegenerative diseases.Harvard NeuroDiscovery Center.Boston, MA: president and fellows of harvard college.2014.Available from: www.neurodiscovery.harvard.edu/challenge/.challengé2.html
3. Lindvall O, Barker RA, Brustle O, et al.Clinical translation of stem cells in neurodegenerative disorders.Cell Stem Cell 2012; 10: 151-5
4. Lunn JS, Sakowski SA, Hur J, et al.Stem cell technology for neurodegenerative diseases.Ann Neurol 2011; 70: 353-61
5. Chaudhuri A, Bhattacharya N.Human fetal tissue transplantation.Springer; London: 2013
6. Tajiri N, Duncan K, Antoine A, et al.Stem cell-paved biobridge facilitates neural repair in traumatic brain injury.Front Syst Neurosci 2014; 8: 116
7. Meamar R, Dehghani L, Ghasemi M, et al.Stem cell therapy in stroke: a review literature.Int J Prev Med 2013; 4: 139-46
8. Lim JY, Jeong CH, Jun JA, et al.Therapeutic effects of human umbilical cord blood-derived mesenchymal stem cells after intrathecal administration by lumbar puncture in a rat model of cerebral ischemia.Stem Cell Res Ther 2011; 2: 1-13
9. Schuepbach WM, Rau J, Knudsen K, et al.Neurostimulation for Parkinson's disease with early motor complications.N Engl J Med 2013; 368: 610-22
10. Ambasudhan R, Dolatabadi N, Nutter A, et al.Potential for cell therapy in Parkinson's disease using genetically programmed human embryonic stem cell-derived neural progenitor cells.J Comp Neurol 2014; 522: 2845-56
11. Glover LE, Tajiri N, Weinbren NL, et al.A step-up approach for cell therapy in stroke: translational hurdles of bone marrow-derived stem cells.Transl Stroke Res 2012; 3(1): 90-8
12. Lescaudron L, Rossignol J, Dunbar GL.Stem cells and neurodegenerative diseases.CRC Press; London: 2014
13. Yasuhara T, Matsukawa N, Hara K, et al.Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson's disease.J Neurosci 2006; 26: 12497-511
14. Ghosh B, Zhang C, Smith GM.Bridging between transplantation therapy and neurotrophic factors in Parkinson's disease.Front Biosci 2014; 6: 225-35
15. Nikkah G, Cunningham MG, Cenci MA, et al.Dopaminergic microtransplants into the substantia nigra of neonatal rats with bilateral 6-OHDA lesions.I.Evidence for anatomical reconstruction of the nigrostriatal pathway.J Neurosci 1995; 15: 3548-61
16. Kriks S, Shim JW, Piao J, et al.Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease.Nature 2011; 480: 547-51
17. Kirkeby A, Grealish S, Wolf DA, et al.Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions.Cell Rep 2012; 1: 703-14
18. Tarazi FI, Sahli ZT, Wolny M, Mousa SA.Emerging therapies for Parkinson's disease: from bench to bedside.Pharmacol Ther 2014; 144: 123-33
19. Study to assess the safety and effects of autologous adipose-derived stromal in patients with parkinson's disease.US National Library of Medicine.Bethesda, MD: US National Library of Medicine.2013.Available from: https://clinicaltrials.gov/ct2/show/NCT01453803?.term=parkinson+stem+cell&rank=5
20. Outcomes data of adispose stem cells to treat Parkinson's disease.US National Library of Medicine.Bethesda, MD: US National Library of Medicine.2013.Available from: https://clinicaltrials.gov/ct2/.show/NCT02184546?term=parkinson+stem+cell&rank=6
21. Safety and clinical outcomes study: SVF deployment for orthopedic, neurologic, urologic, and cardiopulmonary conditions.US National Library of Medicine.Bethesda, MD: US National Library of Medicine.2013.Available from: https://.clinicaltrials.gov/ct2/show/NCT01953523?.term=parkinson+stem+cell&rank=11
22. TRANSEURO open label transplant study in parkinson's disease.US national library of medicine.Bethesda, MD: US National Library of Medicine.2013.Available from: http://clinicaltrials.gov/ct2/show/record/.NCT01898390
23. TRANSEURO report summary.CORDIS.Cambridge, UK: CORDIS.2014.Available from: http://cordis.europa.eu/result/rcn/.52712én.html
24. Fegert JM, Fangerou H, Trapp T.Implanted Minds: the neuroethics of intracerebral stem cell transplantation and deep brain stimulation.Transcript Verlag: Bielefeld; 2011
25. Emerich DF, Thanos CG, Goddard M, et al.Extensive neuroprotection by choroid plexus transplants in excitotoxin lesioned monkeys.Neurobiol Disease 2006; 23: 471-80
26. Baig AM.Designer's microglia with novel delivery system in neurodegenerative diseases.Med Hypotheses 2014; 83: 510-12
27. Mu S, Wang J, Zhou G, et al.Transplantation of induced pluripotent stem cells improves functional recovery in Huntington's disease rat model.PLoS One 2014; 9(7): e101185
28. Borlongan CV, Thanos CG, Skinner SJ, et al.Transplants of encapsulated rat choroid plexus cells exert neuroprotection in a rodent model of Huntington's disease.Cell Transplant 2007; 16: 987-92
29. Bachoud-Levi AC, Remy P, Nguyen JP, et al.Motor and cognitive improvements in patients with Huntington's disease after neural transplantation.Lancet 2000; 356: 1975-9
30. Keene CD, Sonnen JA, Swanson PD, et al.Neural transplantation in Huntington's disease: long term grafts in two patients.Neurology 2007; 68: 2093-8
31. Cicchetti F, Saporta S, Hauser RA, et al.Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration.Proc Natl Acad Sci USA 2009; 106: 12483-8
32. Bachoud-Levi AC, Gaura V, Brugieres P, et al.Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-Term follow-up study.Lancet Neurol 2006; 5: 303-9
33. Jiang W, Buchele F, Papazoglou A, et al.Multitract microtransplantation increases the yield of DARPP-32-positive embryonic striatal cells in a rodent model of Huntington's disease.Cell Transplant 2011; 20: 1515-27
34. A pre-cellular therapy observational study in early Huntingson's disease (PRE-CELL).U.S.National Library of Medicine.Bethesda, MD: US National Library of Medicine.2013.Available from: https://clinicaltrials.gov/ct2/show/study/NCT01937923?.term=huntington%27s+disease+stem+cell&rank=2
35. Kim M, Lee ST, Chu K, Kim SU.Stem cell-based therapy for Huntington's disease: a review.Neuropathology 2008; 28: 1-9
36. What is stroke.National Heart, Lung, and blood institute.Bethesda, MD: national Heart, Lung, and Blood Institute.2014.Available from: www.nhlbi.nih.gov/health/.health-Topics/topics/stroke/
37. Casals JB, Pieri NC, Feitosa ML, et al.The use of animal models for stroke research: a review.Comp Med 2011; 61: 305-13
38. Rodrigues MC, Glover LE, Weinbren N, et al.Toward personalized cell therapies: autologous menstrual blood cells for stroke.J Biomed Biotechnol 2011; 2011: 194720
39. Borlongan CV, Tajima Y, Trojanowski JQ, et al.Cerebral ischemia and CNS transplantation: differential effects of grafted fetal rat striatal cells and human neurons derived from a clonal cell line.Neuroreport 1998; 9: 3703-9
40. Borlongan CV, Kaneko Y, Maki M, et al.Menstrual blood cells display stem cell-like phenotypic markers and exert neuroprotection following transplantation in experimental stroke.Stem Cells Dev 2010; 19: 439-51
41. Kaneko Y, Dailey T, Weinbren NL, et al.The battle of the sexes for stroke therapy: female- versus male- derived stem cells.CNS Neurol Disord Drug Targets 2013; 12: 405-12
42. Chiang YH, Lin SZ, Borlongan CV, et al.Transplantation of fetal kidney tissue reduces cerebral infarction induced by middle cerebral artery ligation.J Cereb Blood Flow Metab 1999; 19: 1329-35
43. Borlongan CV, Lind JG, Dillon-Carter O, et al.Bone marrow grafts restore cerebral blood flow and blood brain barrier in stroke rats.Brain Res 2004; 1010: 108-16
44. Borlongan CV, Skinner SJ, Geaney M, et al.CNS grafts of rat choroid plexus protect against cerebral ischemia in adult rats.Neuroreport 2004; 15: 1543-7
45. Hara K, Yasuhara T, Maki M, et al.Neural progenitor NT2N cell lines from teratocarcinoma for transplantation therapy in stroke.Prog Neurobiol 2008; 85: 318-34
46. Hara K, Matsukawa N, Yasuhara T, et al.Transplantation of post-mitotic human neuroteratocarcinomaoverexpressing Nurr1 cells provides therapeutic benefits in experimental stroke: in vitro evidence of expedited neuronal differentiation and GDNF secretion.J Neurosci Res 2007; 85: 1240-51
47. Tajiri N, Acosta S, Glover LE, et al.Intravenous grafts of amniotic fluid-derived stem cells induce endogenous cell proliferation and attenuate behavioral deficits in ischemic stroke rats.PLoS One 2012; 7(8): e43779
48. Tajiri N, Quach DM, Kaneko Y, et al.Behavioral and histopathological assessment of adult ischemic rat brains after intracerebral transplantation of NSI-566RSC cell lines.PLoS One 2014; 9(3): e91408
49. Ishikawa H, Tajiri N, Shinozuka K, et al.Vasculogenesis in experimental stroke after human cerebral endothelial cell transplantation.Stroke 2013; 44: 3473-81
50. Borlongan CV, Evans A, Yu G, Hess DC.Limitations of intravenous human bone marrow CD133+ cell grafts in stroke rats.Brain Res 2005; 1048: 116-22
51. Borlongan CV, Hess DC.New hope for stroke patients: mobilization of endogenous stem cells.CMAJ 2006; 174: 954-5
52. Nelson PT, Kondziolka D, Wechsler L, et al.Clonal human (hNT) neuron grafts for stroke therapy: neuropathology in a patient 27 months after implantation.Am J Pathol 2002; 160: 1201-6
53. Kondziolka D, Wechsler L, Goldstein S, et al.Transplantation of cultured human neuronal cells for patients with stroke.Neurology 2000; 55: 565-9
54. Kondziolka D, Steinberg GK, Wechsler L, et al.Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial.J Neurosurg 2005; 103: 38-45
55. Autologous bone marrow mesenchymal stem cell transplantation for chronic stroke.US National library of medicine.Bethesda, MD: US National Library of Medicine.2013.Available from: https://clinicaltrials.gov/ct2/show/NCT01714167?term=stem+ cells&recr=Open&nóunk=Y&cond=stroke&rank=1
56. Autologous bone marrow stromal cell and endothelial progenitor cell transplantation in ischemic stroke (AMETIS).US National library of medicine.Bethesda, MD: US National library of medicine.2013.Available from: https://clinicaltrials.gov/ct2/.show/NCT01468064?term=stem+cellsrecr=Open&nóunk=Y&cond=stroke&rank=2
57. Reparative therapy in acute ischemic stroke with allogenic mesenchymal stem cells from adipose tissue, safety assessment, a randomized, double blind placebo controlled single center pilot clinical trial (AMASCIS-01).US National Library of Medicine.Bethesda, MD: US National Library of Medicine.2013.Available from: https://clinicaltrials.gov/ct2/show/.NCT01678534?term=stem+cellsrecr=Open&nóunk=Y&cond=stroke&rank=5
58. Study to assess the safety and effects of autologous adipose-derived stromal cells in patients after stroke.US National Library of Medicine.Bethesda, MD: US National Library of Medicine.2013.Available from: https://clinicaltrials.gov/ct2/show/.NCT01453829?term=stem+cellsrecr=Open&nóunk=Ycond=stroke&rank=10
59. Zhang L, Li Y, Zhang C, et al.Delayed administration of human umbilical tissue-derived cells improved neurological functional recovery in a rodent model of focal ischemia.Stroke 2011; 42: 1437-44
60. Injury prevention & control: traumatic brain injury.Centers for disease control and prevention.Atlanta, GA: centers for disease control and prevention.2014.Available from: www.cdc.gov/TraumaticBrainInjury/.index.html [Last accessed 20 October 2014
61. Hayashi T, Kaneko Y, Yu S, et al.Quantitative analyses of matrix metalloproteinase activity after traumatic brain injury in adult rats.Brain Res 2009; 1280: 172-7
62. Carroll JE, Borlongan CV.Adult stem cell therapy for acute brain injury in children.CNS Neurol Disord Drug Targets 2008; 7: 361-9
63. Borlongan CV, Lind JG, Dillon-Carter O, et al.Intracerebral xenografts of mouse bone marrow cells in adult rats facilitate restoration of cerebral blood flow and blood- brain barrier.Brain Res 2004; 1009: 26-33
64. Harting MT, Sloan LE, Jimenez F, et al.Subacute neural stem cell therapy for traumatic brain injury.J Surg Res 2009; 153: 188-94
65. Tajiri N, Acosta SA, Shahaduzzaman MD, et al.Intravenous transplants of human adipose-derived stem cell protect the brain from traumatic brain injury-induced neurodegeneration and motor and cognitive impairments: cell graft biodistribution and soluble factors in young and aged rats.J Neurosci 2014; 34: 313-26
66. Acosta SA, Tajiri N, Shinozuka K, et al.Combination therapy of human umbilical cord blood cells and granulocyte colony stimulating factor reduces histopathological and motor impairments in an experimental model of chronic traumatic brain injury.PLoS One 2014; 9(3): e90953
67. de la Pena I, Sanberg PR, Acosta S, et al.Stem cells and G-CSF for treating neuroinflammation in traumatic brain injury: aging as a comorbidity factor.J Neurosurg Sci 2014; 58: 145-9
68. Tajiri N, Kaneko Y, Shinozuka K, et al.Stem cell recruitment of newly formed host cells via a successful seduction?.filling the gap between neurogenic niche and injured brain site.PLoS One 2013; 8(9): e74857
69. Shindo T, Matsumoto Y, Wang Q, et al.Differences in the neuronal stem cells survival, neuronal differentiation and neurological improvement after transplantation of neural stem cells between mild and severe experimental traumatic brain injury.J Med Invest 2006; 53: 42-51
70. Safety of autologous stem cell treatment for traumatic brain injury in children.US National Library of Medicine.Bethesda, MD: US National Library of Medicine.2013.Available from: https://clinicaltrials.gov/ct2/show/record/NCT00254722?.term=stem+cells&cond=traumatic+brain+injury&rank=1
71. Stem cell therapy in traumatic brain injury.US National Library of Medicine.Bethesda, MD: US National Library of Medicine.2013.Available from: https://.clinicaltrials.gov/ct2/show/record/.NCT02028104?term=stem+cells&cond=traumatic+brain+injury&rank=3
72. Pediatric autologous bone marrow mononuclear cells for severe traumatic brain injury.US National Library of Medicine.Bethesda, MD: US National Library of Medicine.2013.Available from: https://.clinicaltrials.gov/ct2/show/record/.NCT01851083?term=stem+cells&cond=traumatic+brain+injury&rank=6
73. Treatment of severe adult traumatic brain injury using bone marrow mononuclear cells.US National Library of Medicine.Bethesda, MD: US National Library of Medicine.2013.Available from: https://.clinicaltrials.gov/ct2/show/record/.NCT01575470?term=stem+cells&cond=traumatic+brain+injury&rank=7
74. Effect of recombinant erythropoietin on numbers of circulating progenitor cells in people with persistent symptoms during the subacute period after traumatic brain injury.US National Library of Medicine.Bethesda, MD: US National Library of Medicine.2013.Available from: https://.clinicaltrials.gov/ct2/show/NCT02226848?.term=stem+cells&cond=traumatic+brain+injury&rank=2
75. Hefferan MP, Johe K, Hazel T, et al.Optimization of immunosuppressive therapy for spinal grafting of human spinal stem cells in a rat model of ALS.Cell Transplant 2011; 20: 1153-61
76. Glass JD, Boulis NM, Johe K, et al.Lumbar intraspinal injection of neural stem cells in patients with amyotrophic lateral sclerosis: results of a phase 1 trial in 12 patients.Stem Cells 2012; 30: 1144-51
77. Clinical trial on the use of autologous bone marrow stem cells in Amyotrophic Lateral Sclerosis (Extension CMN/ELA).US National Library of Medicine.Bethesda, MD: US National Library of Medicine.2013.Available from: https://clinicaltrials.gov/ct2/show/study/NCT01254539?.term=stem+cell&cond=amyotrophic+lateral+sclerosis&rank=1
78. Safety and efficacy study of autologous bone marrow derived stem cell treatment in amyotrophic lateral sclerosis.US National library of medicine.Bethesda, MD: US National Library of Medicine.2013.Available from: https://clinicaltrials.gov/ct2/.show/record/NCT01363401?term=stem+cell&cond=amyotrophic+lateral+sclerosis&rank=12
79. Dose escalation and safety study of human spinal cord derived neural stem cell transplantation for the treatment of amyotrophic lateral sclerosis.US National Library of Medicine.Bethesda, MD: US National Library of Medicine.2013.Available from: https://clinicaltrials.gov/ct2/.show/study/NCT01730716?term=stem+cell&cond=amyotrophic+lateral+sclerosis&rank=3
80. Biological treatment of Amyotrophic Lateral Sclerosis (NeuStem-ALS).US National Library of Medicine.Bethesda, MD: US National Library of Medicine.2013.Available from: https://clinicaltrials.gov/ct2/.show/record/NCT02193893?term=stem+cell&cond=amyotrophic+lateral+sclerosis&rank=10
81. Stem cell therapy for Amyotrophic Lateral Sclerosis.US National Library of Medicine.Bethesda, MD: US National Library of Medicine.2013.Available from: https://clinicaltrials.gov/ct2/show/record/.NCT01984814?term=stem+cell&cond=amyotrophic+lateral+sclerosis&rank=16
82. The clinical trial on the use of umbilical cord mesenchymal stem cells in Amyotrophic Lateral Sclerosis.US National Library of Medicine.Bethesda, MD: US National Library of Medicine.2013.Available from: https://clinicaltrials.gov/ct2/show/study/NCT01494480?.term=stem+cell&cond=amyotrophic+lateral+sclerosis&rank=2
83. Human spinal cord derived neural stem cell transplantation for the treatment of Amyotrophic Lateral Sclerosis (ALS).US National Library of Medicine.Bethesda, MD: US National Library of Medicine.2014.Available from: https://clinicaltrials.gov/ct2/show/study/NCT01348451?.term=stem+cell&cond=amyotrophic+lateral+sclerosis&rank=5
84. Effect of intrathecal administration of hematopoietic stem cells in patients with Amyotrphic lateral sclerosis (ALS).US National Library of Medicine.Bethesda, MD: US National Library of Medicine.2014.Available from: https://clinicaltrials.gov/ct2/show/study/NCT01933321?.term=stem+cell&cond=amyotrophic+lateral+sclerosis&rank=4
85. Mesenchymal stem cell injection in amyotrophic lateral sclerosis.US national library of medicine.Bethesda, MD: US National Library of Medicine.2014.Available from: https://clinicaltrials.gov/ct2/.show/study/NCT02116634?term=stem+cell&cond=amyotrophic+lateral+sclerosis&rank=6
86. A dose-escalation safety trial for intrathecal autologous mesenchymal stem cell therapy in Amyotrophic Lateral Sclerosis.US National Library of Medicine.Bethesda, MD: US National Library of Medicine.2014.Available from: https://clinicaltrials.gov/ct2/show/study/NCT01609283?.term=stem+cell&cond=amyotrophic+lateral+sclerosis&rank=11
87. Mesenchymal stem cells for treatment of Amyotrophic Lateral Sclerosis (ALS).US National Library of Medicine.Bethesda, MD: US National Library of Medicine.2014.Available from: https://clinicaltrials.gov/ct2/show/record/NCT01142856?.term=stem+cell&cond=amyotrophic+lateral+sclerosis&rank=13
88. Human neural stem cell transplantation in Amyotrophic Lateral Sclerosis (ALS) (hNSCALS).US National Library of Medicine.Bethesda, MD: US National Library of Medicine.2012.Available from: https://clinicaltrials.gov/ct2/show/study/.NCT01640067?term=stem+cell&cond=amyotrophic+lateral+sclerosis&rank=7
89. Safety study of HLA-haplo matched allogenic bone marrow derived stem cell treatment in Amyotrophic Lateral Sclerosis.US National Library of Medicine.Bethesda, MD: US National Library of Medicine.2014.Available from: https://.clinicaltrials.gov/ct2/show/study/.NCT01758510?term=stem+cell&cond=amyotrophic+lateral+sclerosis&rank=8
90. Derivation of induced pluripotent stem cells from an existing collection of human somatic cells.US National Library of Medicine.Bethesda, MD: US National Library of Medicine.2014.Available from: https://clinicaltrials.gov/ct2/show/.NCT00801333?term=stem+cells&cond=amyotrophic+lateral+sclerosis&rank=20
91. The effect of GCSF in the treatment of ALS patients.US national library of medicine.bethesda, MD: US national library of medicine.2013.Available from: https://clinicaltrials.gov/ct2/show/.NCT01825551?term=stem+cells&cond=amyotrophic+lateral+sclerosis&rank=25
92. Karussis D, Grigoriadis S, Polyzoidou E, et al.Neuroprotection in multiple sclerosis.Clin Neurol Neurosurg 2006; 108: 250-4
93. Wang X, Kimbrel EA, Ijichi K, et al.Human ESC-derived MSCs outperform bone marrow MSCs in the treatment of an EAE model of multiple sclerosis.Stem Cell Reports 2014; 3: 115-30
94. Donders R, Vanheusden M, Bogie JF, et al.Human Wharton's jelly-derived stem cells display immunomodulatory properties and transiently improve rat experimental autoimmune encephalomyelitis.Cell Transplant 2014.[Epub ahead of print
95. Li JF, Zhang DJ, Geng T, et al.The potential of human umbilical cord-derived mesenchymal stem cells as novel cellular therapy for multiple sclerosis.Cell Transplant 2014.23(Suppl 1): S113-22
96. Safety and efficacy of autologous bone marrow mesenchymal stem cells in multiple sclerosis.US National Library of Medicine.Bethesda, MD: US National Library of Medicine.2013.Available from: http://.clinicaltrials.gov/ct2/show/NCT01895439?.term=stem+cells&cond=multiple+sclerosis&rank=1
97. Feasibility study of human umbilical cord tissue-derived mesenchymal stem cells in patients with multiple sclerosis.US National Library of Medicine.Bethesda, MD: US National Library of Medicine.2014.Available from: http://clinicaltrials.gov/ct2/show/NCT02034188?term=stem+cells&cond=multiple+sclerosis&rank=5
98. Lee PH, Lee JE, Kim HS, et al.A randomized trial of mesenchymal stem cells in multiple system atrophy.Ann Neurol 2012; 72: 32-40
99. Herberts CA, Kwa MS, Hermsen HP.Risk factors in the development of stem cell therapy.J Transl Med 2011; 9: 29
100. Emborg ME, Zhang Z, Joers V, et al.Intracerebral transplantation of differentiated human embryonic stem cells to hemiparkinsonian monkeys.Cell Transplant 2013; 22: 831-8
101. Leveque X, Mathieux E, Nerriere-Daguin V, et al.Local control of the host immune response performed with mesenchymal stem cells: perspectives for functional intracerebral xenotransplantation.J Cell Mol Med 2014; 19(1): 124-34
102. Sohni A, Verfaillie CM.Mesenchymal stem cells migration homing and tracking.Stem Cells Int 2013; 2013: 130763
103. de la Pena I, Pabon M, Acosta S, et al.Oligodendrocytes engineered with migratory proteins as effective graft source for cell transplantation in multiple sclerosis.Cell Med 2014; 6: 123-7
104. Yasuhara T, Hara K, Maki M, et al.Intravenous grafts recapitulate the neurorestoration afforded by intracerebrally delivered multipotent adult progenitor cells in neonatal hypoxic-ischemic rats.J Cereb Blood Flow Metab 2008; 28: 1804-10
105. Edelstein SA, Holmes LP.Seeking novel treatments abroad.Stem cell tourism: risks, legal issues and mitigation-proceeding of the STEMSO conference.CellR4 2014; 2: e700
106. Patient advisory for stem cell therapy and medical tourism.California Institute for Regenerative Medicine.San Francisco, CA: california Institute for Regenerative Medicine.2013.Available from: www.cirm.ca.gov/about-cirm/newsroom/press-releases/.08192013/patient-Advisory-stem-celltherapy-And-medical-Tourism
107. Board on Health Sciences Policy, Board on Life Sciences, Divisions on Earth and Life Studies et al.Stem cell therapies: opportunities for ensuring the quality and safety of clinical offerings: summary of a joint workshop.National Academies Press; Washington, DC: 2014